Adaptimmune Therapeutics Statistics
Total Valuation
ADAP has a market cap or net worth of $79.18 million. The enterprise value is $1.78 million.
Important Dates
The next confirmed earnings date is Tuesday, May 13, 2025, before market open.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ADAP has 263.92 million shares outstanding. The number of shares has increased by 25.48% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 263.92M |
| Shares Change (YoY) | +25.48% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.66% |
| Owned by Institutions (%) | 12.85% |
| Float | 182.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| Forward PS | 2.17 |
| PB Ratio | 6.48 |
| P/TBV Ratio | 9.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.92, with a Debt / Equity ratio of 6.26.
| Current Ratio | 2.92 |
| Quick Ratio | 2.60 |
| Debt / Equity | 6.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.65 |
Financial Efficiency
Return on equity (ROE) is -275.74% and return on invested capital (ROIC) is -43.44%.
| Return on Equity (ROE) | -275.74% |
| Return on Assets (ROA) | -12.39% |
| Return on Invested Capital (ROIC) | -43.44% |
| Return on Capital Employed (ROCE) | -28.89% |
| Revenue Per Employee | $351,842 |
| Profits Per Employee | -$139,949 |
| Employee Count | 506 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 34.25 |
Taxes
In the past 12 months, ADAP has paid $3.58 million in taxes.
| Income Tax | 3.58M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.73% in the last 52 weeks. The beta is 2.85, so ADAP's price volatility has been higher than the market average.
| Beta (5Y) | 2.85 |
| 52-Week Price Change | -72.73% |
| 50-Day Moving Average | 0.33 |
| 200-Day Moving Average | 0.70 |
| Relative Strength Index (RSI) | 53.98 |
| Average Volume (20 Days) | 785,060 |
Short Selling Information
| Short Interest | 4.59M |
| Short Previous Month | 5.45M |
| Short % of Shares Out | 2.67% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.55 |
Income Statement
In the last 12 months, ADAP had revenue of $178.03 million and -$70.81 million in losses. Loss per share was -$0.30.
| Revenue | 178.03M |
| Gross Profit | 28.90M |
| Operating Income | -52.41M |
| Pretax Income | -162.17M |
| Net Income | -70.81M |
| EBITDA | -41.18M |
| EBIT | -52.41M |
| Loss Per Share | -$0.30 |
Full Income StatementBalance Sheet
The company has $151.61 million in cash and $74.21 million in debt, giving a net cash position of $77.40 million or $0.29 per share.
| Cash & Cash Equivalents | 151.61M |
| Total Debt | 74.21M |
| Net Cash | 77.40M |
| Net Cash Per Share | $0.29 |
| Equity (Book Value) | 11.85M |
| Book Value Per Share | 0.05 |
| Working Capital | 123.64M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$73.21 million and capital expenditures -$886,000, giving a free cash flow of -$74.09 million.
| Operating Cash Flow | -73.21M |
| Capital Expenditures | -886,000 |
| Free Cash Flow | -74.09M |
| FCF Per Share | -$0.28 |
Full Cash Flow StatementMargins
Gross margin is 16.23%, with operating and profit margins of -29.44% and -39.78%.
| Gross Margin | 16.23% |
| Operating Margin | -29.44% |
| Pretax Margin | -37.77% |
| Profit Margin | -39.78% |
| EBITDA Margin | -23.13% |
| EBIT Margin | -29.44% |
| FCF Margin | n/a |
Dividends & Yields
ADAP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.48% |
| Shareholder Yield | -25.48% |
| Earnings Yield | -89.44% |
| FCF Yield | -93.58% |
Analyst Forecast
The average price target for ADAP is $1.83, which is 510.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $1.83 |
| Price Target Difference | 510.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 7.39% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ADAP has an Altman Z-Score of -4.94 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.94 |
| Piotroski F-Score | 3 |